Evidence map›Paper›PMID 38697196›Full record

ArticleNature2024

A deconstruction-reconstruction strategy for pyrimidine diversification.

Benjamin J H Uhlenbruck, Celena M Josephitis, Louis de Lescure, Robert S Paton, Andrew McNally

Abstract read
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lactam Framework Editing via Formal Methylene Deletion.Journal of the American Chemical Society · 2026
    Article
  8. Pyridine C─N Transposition via Cycloaddition-Cycloreversion.Angewandte Chemie (International ed. in English) · 2026
    Article
  9. Shape-Conserving Atom Replacements.Chemical reviews · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benjamin J H UhlenbruckDepartment of Chemistry, Colorado State University, Fort Collins, CO, USA.
Celena M JosephitisDepartment of Chemistry, Colorado State University, Fort Collins, CO, USA.
Louis de LescureDepartment of Chemistry, Colorado State University, Fort Collins, CO, USA.
Robert S PatonDepartment of Chemistry, Colorado State University, Fort Collins, CO, USA. Robert.paton@colostate.edu.ORCID 0000-0002-0104-4166
Andrew McNallyDepartment of Chemistry, Colorado State University, Fort Collins, CO, USA. andy.mcnally@colostate.edu.ORCID 0000-0002-8651-1631

Funding

A New General Strategy for Pyridine Functionalization via Dearomatized IntermediatesR01GM144591 · NIGMS · COLORADO STATE UNIVERSITY · PI MCNALLY, ANDREW · 2022 to 2025
$1.2M
NIGMS NIH HHS R01 GM144591
6 · The paper itself

Abstract

Structure-activity relationship (SAR) studies are fundamental to drug and agrochemical development, yet only a few synthetic strategies apply to the nitrogen heteroaromatics frequently encountered in small molecule candidates

Indexed as

Chemistry Techniques, SyntheticPyrimidinesAzolesNitrogenStructure-Activity RelationshipAzolesNitrogenpyrimidinePyrimidines

Identifiers

PMID38697196
PMCPMC11421208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.